# REGENXBIO Inc.: Form DEF 14A, filed Apr 14, 2026

- Company: [REGENXBIO Inc.](/companies/rgnx.md) (CIK 1590877)
- Form: DEF 14A
- Filed: 2026-04-14
- Accepted by EDGAR: Apr 14, 2026, 17:00 ET
- Period: 2026-05-29
- Accession: 0001193125-26-155058
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1590877/000119312526155058/rgnx-20260414.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590877/000119312526155058/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1590877/000119312526155058/rgnx-20260414.htm

Filed Apr 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-155058. Last ingested by Listed: Nov 10, 2026, 17:27 ET. No prices; not investment advice.
